In ovariectomized mice (an animal model for menopause), estrogen replacement increased GLP-1 secretion from both intestinal L-cells and pancreatic alpha-cells
Glucose Control PRO May Fit When: Post-meal glucose regulation is the primary target The patient has type 2 diabetes or significant glycemic concerns A clinician wants the formulation with the most direct human glycemic evidence Medication, glucose monitoring and nutrition are being managed concurrently Claims that it treats PCOS, reverses insulin resistance or replaces diabetes medication would extend beyond the available product-specific evidence
In NM hospitals, 15.2% (21 475) of patients have identified needs
Regular exercise, for instance, not only strengthens the lungs and heart but can also improve overall balance and reduce feelings of dizziness
Gut Microbes 17, 2489070
Many thanks to Joseph Zucchi, PA-C, MPAS for sharing Clinical Supervisor & Physician Associate at Transition Medical Weight Loss | Obesity Medicine Speaker & Writer ADA 2026 made one thing clear: obesity medicine is moving fast
